Prothena reported 44.52M in Operating Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Acadia Pharmaceuticals ACAD:US $ 168.21M 60.27M
Agios Pharmaceuticals AGIO:US $ 100.52M 1.24M
Akebia Therapeutics AKBA:US $ 74.26M 45.93M
ALKERMES ALKS:US 310.68M 5.55M
Alnylam Pharmaceuticals ALNY:US $ 416.5M 56.51M
Amgen AMGN:US $ 4.42B 680M
Biogen BIIB:US $ 2648.2M 727.1M
Biomarin Pharmaceutical BMRN:US $ 494.65M 112.61M
Bluebird Bio BLUE:US $ 108.92M 13.37M
Exelixis EXEL:US $ 335.72M 62.98M
Intercept Pharmaceuticals ICPT:US $ 85.12M 13.73M
Intra Cellular Therapies ITCI:US $ 143.5M 35.84M
IONIS PHARMACEUT IONS:US $ 219.3M 19.88M
Macrogenics MGNX:US $ 67.82M 9.92M
Nektar Therapeutics NKTR:US $ 174.42M 33.04M
Neurocrine Biosciences NBIX:US $ 393.5M 86M
Prothena PRTA:US 44.52M 5.42M
Regeneron Pharmaceuticals REGN:US $ 1747.3M 40.7M
Seattle Genetics SGEN:US $ 630.61M 71.1M
Ultragenyx Pharmaceutical RARE:US $ 230.94M 14.37M
Vertex Pharmaceuticals VRTX:US $ 1089.9M 33.3M
Vital Therapies VTL:US $ 20.61M 825K
Xoma XOMA:US $ 5.75M 578K
YTE INCY:US $ 656.97M 40.27M